topper's finally got some new material, page-43

re: re:positive sirtex trials and profit jump up Also with Cephalon 2 years ago willing to pay $4.85 a share, and now Pfizer and Sanofi involved in a successful small profitable Sirtex co and their Sir Spheres therapy with their chemo drugs , I'm quite confident that an aging DR Gray who has 13 million shares and $26 million of his own money in it, would easily let it go for the right price. Thats why the share is a good value here with all the progress made since the bid 2 years ago.